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1

types of dural substitutes have been used to deal with dural defects. These
play an important role in dural repair. Dural substitutes have gradually
reached researchers, neurosurgeons, and patients for approval. This article
summarizes the structural characteristics of the dura mater and its
regeneration after injury, and reviews the state of progress in research and
application. It will provide a reference for the development and application
of dural substitutes.

Introduction

Tumor erosion, neurosurgical operations, and
severe trauma can cause dural defects in the
central nervous system. During the dural repair
process, it is necessary to prevent cerebrospinal
fluid leakage, intracranial infection, adhesion,
and other complications. Since the last century,
scientists have been trying to create better dural
substitutes to improve the repair process and
reduce complications. Dozens of dural substitutes
have been reported in the literature; these can be
divided into four categories: autologous tissue
materials, allogeneic tissue materials, xenogeneic
materials, and macromolecular polymer materials.
Each dural substitute has its own advantages
and disadvantages. As there is no definitive

evidence to prove that one type has absolute
predominance over other types, the optimal
choice of materials for use in dural repair
procedures remains unclear. In order to describe
the structure and characteristics of the human dura
mater, this paper reviews the research progress
and application of dural substitutes along with
their basic mechanism after implantation. It will
serve as a reference for the selection of dural
substitutes in clinical practice and the development
of new-generation materials.

2

2.1

Structural characteristics of dura mater
and its regeneration after injury
Structure of dura mater

The dura mater is an opaque and tough fibrous
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membrane that covers the brain and spinal cord.
On the basis of its location, the dura mater is
divided into the cerebral dura mater and spinal
dura mater.
The dura mater consists primarily of collagen
fibers arranged in layers, which are generally
divided into two parts. The outer layer is called
the endosteal layer, which is the periosteum of
the inner surface of the skull. This layer is loosely
attached to the inner surface of the skull but is
more difficult to strip from cranial sutures and
the skull base. The inner layer of the dura mater
is called the meningeal layer and is thicker, tougher,
and more durable than the endosteal layer. In
addition to being separated at the dural sinus,
the two meningeal layers are fused at other parts,
and there are blood vessels and nerves running
through them [1]. In 2015, Louveau reported
lymphatic vessels parallel to the dural sinus, which
was the first report of the meningeal lymphatic
vessels [2]. The structure of the dura mater is
mainly composed of collagen fibers with elastic
fibers. There are a few fibroblasts in the dura mater
and osteoblasts in the periosteum. Kegel reported
that the average thickness of human dura mater
is 1.06 ± 0.22 mm [3]. Noort examined the dura
mater of 16 fresh human cadavers who died at
20 to 77 years of age. The average failure stress
of the human dura mater was 4.70 MPa (range:
3.28 MPa–7.86 MPa), and the average failure strain
was 18.4% (range: 16.0%–21.1%) [4]. Chauvet
found that the amount of collagen fibers in the
dura mater decreased gradually from the inner
layer to the outer layer, whereas the amount of
elastic fibers increased. It was also observed under
scanning electron microscopy that the dura mater
of human beings had a multi-layered structure.
On the basis of the results of scanning electron
microscopy [5], Protasoni further divided human
dura mater into five different layers—the bone
surface layer, external median layer, vascular

layer, internal median layer, and arachnoid layer
—based on the 3D architecture, disposition, and
orientation of the collagen fibers. The change in
direction of the collagen fibers is mostly visible
between the vascular and internal median layers,
where they are subjected to the highest stretching
forces. This allows neurosurgeons to distinguish
the two layers of the dura mater [6].
Spinal dura mater is the outer layer of the spinal
cord capsule, covering the arachnoid membrane,
the pia mater, and the spinal cord, which
corresponds to the dura mater’s inner layer
and continues to the dura mater at the foramen
magnum [7]. Spinal dura mater can be divided
into three layers: an outer layer consisting of
collagen fibers and elastic fibers with an average
thickness of about 2 μm; a median layer that
is thick and strong, with blood vessels but no
innervation; and an inner layer that is connected
with the arachnoid membrane, with an average
thickness of about 8 μm [8]. As the location of
spinal dura mater is lower than that of the
cerebral dura mater, it bears higher hydrostatic
pressure, so it must be more watertight.
2.2

Repair and regeneration of the dura mater

The function of the dura mater is to support and
protect the central nervous system and create
relatively closed conditions for the circulation of
cerebrospinal fluid. When a dural defect is small,
it can be repaired by suture. When a dural defect
caused by trauma, surgical breakage, or tumor
infiltration is large, it must be repaired by dural
substitutes. Dural substitutes can prevent the
injured area of the brain or spinal cord from
reaching other tissues and effectively recover
the watertightness of the original structure. The
repair of dura mater with dural substitutes
can effectively reduce the incidence of epilepsy,
cerebrospinal fluid leakage, infection, and other
complications.
Journal of Neurorestoratology
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After implantation of the dural substitute,
the reconstruction of regenerated dura mater is
synchronized with the degradation of the graft.
Fibroblasts are the key cells in these two processes.
The implanted dural substitute provides a scaffold
for the migration and implantation of fibroblasts,
lymphocytes, macrophages, and other cells that
secrete collagen fibers, elastic fibers, reticular
fibers, proteoglycan, and glycoprotein in the process of dural reconstruction. At the same time,
the matrix metalloproteinases (MMPs) secreted by
fibroblasts and other cells degrade the implanted
collagen-based dural substitute, together with
some non-specific proteases and peptidases.
MMPs are a group of zinc-dependent enzymes
that regulate cell matrix composition. MMPs-1, 8,
and 13 are human endogenous enzymes known
to decompose fibrous collagen in vivo [9]. In type-I
collagen, which is the main component of most
dural substitutes, each triple-helical unit is
composed of two α1 chains and one α2 chain.
MMP-mediated collagen degradation preferentially
occurs at the site on the α2 chain, breaking the
chain into three quarter- and one quarter-length
fragments (molecular weights of about 75,000
and 250,000, respectively). Consequently, these
two fragments are degraded into oligopeptides
or amino acids by a variety of non-specific
proteases [10]. The degradation time of a dural
substitute is related to the composition, size, and
thickness of the material, preparation processing,
the location of the graft, and other factors. Laun
et al. reported that fibroblasts and histocytes
began to migrate to the dural substitute implanted
into a patient on the fourth day after operation
and entered the graft through pores in the
fibers [11]. Three months after the operation, the
thickness of a graft made of bovine pericardium
was reduced by half, and the thick collagen fibers
on the surface of the graft were replaced by new,
slim fibers. At 24 months after the operation, the
thickness of the graft was only about 1/10. Good
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vascularization could be seen in the transition
region between the new tissue and implanted
dural substitutes [11]. In addition, it has been
reported that dural substitutes made of pure
collagen extracted from equine Achilles tendon are
completely degraded 1 year after implantation in
the patient’s body and that the regenerated dura
mater has an ideal structure [12]. However, the
degradation process of macromolecular polymer
material used in dural substitutes has rarely been
reported in detail.

3

Development and application of dural
substitutes

In the last hundred years, scholars from all
over the world have used hundreds of different
materials to prepare dural substitutes: Abbe first
reported using rubber patches to repair dura
mater in 1895 [13]. Craig and Ellis first reported
the use of animal-derived materials to repair the
dura mater in 1905. The dural substitute used
in the operation, which was made from bovine
peritoneum, was called Cargile membrane [14].
Subsequently, scholars in various countries have
tried to repair the dura mater with materials
obtained from animal pericardium, allantoic
membrane, amniotic membrane, and other animal
sources. In 1926, Dandy successfully repaired the
dura mater with autologous fascia lata for the
first time [15]. In 1958, Campbell and Sharkey
reported that freeze-dried allogenic dura mater
could be used as a dural substitute and achieved
clinical success for the first time [16, 17]. Over
the next three decades, this type of material was
commercialized and widely used in duraplasty
in various countries. In 1991, Gortler verified the
feasibility of expanded polytetrafluoroethylene
as a synthetic polymer material for dural transplantation in animal experiments for the first
time, and its clinical effect was confirmed [18]. In
this century, polyglycolic acid (PGA), L-lactic acid
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and epsilon-caprolactone copolymers, polyglactin
910 copolymers, and polydioxycyclohexanone
blended fabrics have been used clinically. There
are dozens of raw materials available for the
preparation of dural substitute. On the basis
of the sources of these raw materials, dural
substitutes can be divided into four categories.
Here we introduce the development and application of each type.
3.1

Autologous tissue materials

This type of dural substitute is taken from
the patient's skull periosteum, fascia lata, cap
aponeurosis, or temporal muscle fascia before or
during the operation to repair the dural defect
[19, 20]. In duraplasty, the cranial periosteum can
be obtained directly and easily without a second
operation, so it is more popular than other
autologous tissues for dural repair. Autologous
materials can effectively avoid the risk of immune
rejection and potential transmission of pathogenic
microorganisms and reduce medical costs. However,
the size and shape of autologous tissue are often
limited, so it is not suitable for repairing large
dural defects.

reported that the dura mater of CJD patients
was used after their death to prepare the dural
substitute, which caused the spread of this disease.
Considering the use of dural substitutes involved,
this disease is named dura mater graft-associated
CJD (dCJD). Prions are the pathogen involved in
dCJD, which are distorted proteins encoded by
the genes of normal host cells. Although they do
not contain nucleic acid, they are self-proliferating
and infectious. The titer of prions in the central
nervous system is much higher than that in other
parts, and there is no simple and reliable detection
method for prions [23]. Therefore, dural substitutes
made from allogeneic dura mater were gradually
withdrawn from the historical stage when the
source of the dura mater was insufficient and the
transmission of prions could not be completely
avoided [24, 25]. Domestic and foreign scholars
have also tried to use amniotic membrane, dermis,
and other allogenic materials to prepare dural
substitutes and have achieved some positive
results [26–28]. However, owing to the lack of
sources of allogenic materials, this type of material
has not been widely used.
3.3

3.2

Allogeneic tissue materials

In 1957, freeze-dried human cadaveric dura mater
was successfully applied to repair a patient’s dural
defect [17]. This kind of artificial dura mater
became popular all over the world in the next
30 years and was widely applied in clinical use
[21]. In 1988, however, a report revealed a case
of progressive dementia, convulsions, and other
clinical symptoms, as well as pathological features
of amyloid plaques and spongiform degeneration
in brain tissue, which were consistent with the
characteristics of Creutzfeldt–Jakob disease (CJD)
[22]. Since that time, similar cases have been found
all over the world. Most of the dural substitutes
involved are Lyodura brand products. It was

Xenogeneic materials

The use of porcine, bovine, equine, and other
animal tissues to prepare dural substitutes has a
history of more than 100 years, and this type of
artificial dura mater is the most commonly used
in clinics at present [29]. On the basis of their
preparation methods, these types of dural substitutes can be divided into two subtypes: one that
keeps the original morphology of animal tissues
and a second that is prepared using extracted
animal collagen. The former maintains the structure of fibrous scaffolds in the extracellular matrix
of animal tissues (such as bovine or porcine heart
capsule, dermis, and small intestinal submucosa)
and is prepared by freeze-drying, cross-linking,
or decellularized treatment [30, 31]. The latter
Journal of Neurorestoratology
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is extracted from tissues rich in collagen (such
as bovine or equine Achilles tendon) to form
collagen-based dural substitutes [32]. Type I
collagen is the main component of the artificial
dura mater that is created, and the scaffold
structure formed by crisscrossing collagen fibers
provides a favorable microenvironment for
reconstruction of the dura mater. Some scholars
believe, however, that the use of animal-derived
materials such as bovine or porcine tissue might
increase the risk of disease transmission, so they
have attempted to use fish tissue to prepare
dural substitutes [33, 34].
3.4

Macromolecular polymer materials

In order to avoid the spread of pathogens caused
by the use of allogeneic or xenogeneic materials,
improve clinical efficacy, and reduce costs,
researchers have attempted to use various synthetic
polymers to prepare dural substitutes. On the
basis of their degradation after implantation,
synthetic substitutes can be subdivided into two
subtypes: nonabsorbable materials and absorbable
materials. The former is represented by expanded
polytetrafluoroethylene and polyurethane dural
substitute, and the latter is composed of PGA,
copolymer of L-lactic acid and epsilon-caprolactone, or copolymer of lactide and polydioxanone.
Absorbable materials are difficult to degrade
in vivo, which can lead to foreign body reactions,
friction with the cerebral cortex or spinal cord,
and other postoperative complications, and the
advent of absorbable materials to a certain extent
results in the deficiencies above [35–37].
Polymers are stretched into filaments by
electrospinning, and a three-dimensional structure
similar to the natural dural structure is formed.
This bionic and porous scaffold provides holes
or cracks, which is beneficial to the migration of
patient’s autologous cells. The migration of cells
is important for the degradation of implanted
materials and the reconstruction of the dura mater
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[38]. In addition, by changing the composition
and concentration of each polymer, the toughness
of the fibers can be adjusted, and the appropriate
level of mechanical strength of the synthetic
dural substitute can be obtained [39]. However,
ensuring the watertightness of the material is an
important issue for its clinical application and is
particularly critical for repairing spinal dura mater
(spinal dura mater bears higher hydrostatic
pressure than cerebral dura mater). Some scholars
have tried to improve the watertightness of dural
substitutes by controlling the size of fiber pores
and adding hydrophobic material to the surface
of synthetic substitutes [40].
Another important question is how to adjust
the degradation rate of the synthetic dural substitute to an ideal range and obtain biological
activity similar to that of collagen. Combining
a polymer with other components for the preparation of synthetic dural substitutes is a good
way to ensure watertightness. For example, the
poly (lactic-co-glycolic acid) (PLGA) is nontoxic
and is widely used in many fields such as
biological scaffold materials, drug delivery systems,
and surgical sutures. The degradation of the
material can be controlled by changing the ratio
of lactic acid to glycolic acid. A dural substitute
made of PLGA and polydioxanone has both
proper degradability and watertightness [39].
It was approved by the Food and Drug
Administration of the United States in 2016 and
has good clinical results. Compared with collagenbased dural substitutes, synthetic macromolecular
materials lack the biological functions of inducing
cell migration and promoting the secretion of
related cytokines. Some researchers have attempted
to prepare dural substitutes by adding gelatin or
silk fibroin into the polymer. This method not
only ensures the bionic structure of the dural
substitute but also increases the biological function
and improves the surface properties of the material,
thereby enhancing its repair effects [38].
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4 Preparation of dural repair materials
The major function of dura mater is to form a
central, airtight system. Trauma or surgery often
results in the absence of arachnoid and pia mater.
Thus, the dural substitutes contact the cerebral
cortex or spinal cord directly after the duraplasty
operation. This direct contact might lead to friction
between the graft and nervous tissue when the
intracranial pressure changes greatly, which can
damage the delicate cerebral cortex or spinal cord.
Therefore, dural substitutes not only should have
good watertightness to prevent cerebrospinal fluid
leakage but also should be smooth and flexible
to avoid the damage of nerve tissue caused by
friction. Therefore, the question of how to reasonably prepare dural substitutes that meet the
requirements is the subject of continuing research.
The preparation of dural substitutes often involves
the following techniques.
4.1

Vacuum freeze-drying technology

This refers to a technology that freezes waterbearing materials into solids. Ice in biomaterials
sublimates directly from a solid form to a gas
under low temperature and pressure conditions,
thereby achieving the purpose of drying. After
freeze-drying treatment, the structure of the
material is porous, like a fluffy porous sponge,
and the volume of the material is basically the
same or slightly larger than that of the original
[33]. It has been reported that after freeze-drying
of animal tissues, the structure of fibrous scaffolds
in the extracellular matrix remains basically
unchanged, some proteins can maintain good
biological activity, and the structure of the
cell membrane is destroyed, which reduces the
antigenicity of this material [41, 42]. Freeze-dried
dural substitute is conducive to long-term preservation. It can be rehydrated and restored to its
original flexible texture by immersion in sterile

saline for several minutes before use. Furthermore,
the porous structure generated in dural substitutes
after vacuum freeze-drying treatment creates
better conditions for the patient’s autologous cells
to migrate and multiply, which is conducive to
the reconstruction of the dura mater [34].
4.2

Acellular technology

Acellular treatment is a technology that removes
cells from human or animal tissues and organs. It
has been reported that acellular tissue can reduce
the immunogenicity of allogenic or xenogenic
materials [42]. SDS is one of the ideal and widely
used methods in the acellular process, but the
residual surfactant in the material has an impact
on tissue regeneration. Therefore, scholars in
various countries are exploring more physical
methods such as gamma ray, repeated freezethaw, and enzymatic methods to remove cell
components in the preparation of artificial dura
mater in order to obtain materials without
surfactant residues [42, 43]. Furthermore, in the
process of acellularization, the fibrous scaffold of
the extracellular matrix can be destroyed, which
decreases the mechanical strength of the material.
Therefore, one study used different freeze-thaw
temperatures, chemical detergents, and incubation
times in order to determine the optimal method
for cell removal. The authors found that a porcine
decellularization method including a freeze-thaw
in liquid nitrogen, an ionic detergent (0.1% SDS),
and a 24 h incubation period resulted in a scaffold
that retained the necessary components, the
ultrastructure of the extracellular matrix (ECM),
and the biomechanical properties. This method
could greatly reduce the immunogenicity of the
material as well [44].
4.3

Cross-link technology

Cross-linking refers to the process in which
polymers (natural or synthetic) are linked to other
Journal of Neurorestoratology
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polymers through covalent or ionic bonds. The
technology of physical or chemical cross-linking
is widely used in the preparation of dural substitutes and can improve the chemical and biomechanical properties of the original materials.
One common method is the use of glutaric
dialdehyde to increase the mechanical strength
and anti-degradation ability of the dural substitute.
However, the remaining glutaraldehyde or other
aldehyde cross-linking agents, to some extent,
prevent the migration and proliferation of a
patient’s cells into the dural substitute, which
restricts the regeneration and repair of the dura
mater. In order to overcome these shortcomings,
physical cross-linking methods and other crosslinking agents with lower toxicity such as carbodiimide have been used in recent years [43,
45]. Synthetic polymer materials lack specific
cell recognition signals and cannot induce cell
migration and adhesion effectively, and some
collagen-based substitutes are limited by low
mechanical properties and excessive degradation
speed in vivo. Therefore, obtaining higher biocompatibility and proper mechanical properties
of high-polymer materials or even a collagenbased matrix is a great challenge. Polydopamine
(PDA) coated cross-linking strategies provide a
possibility. Owing to PDA’s robust capacity to
deposit onto the various surfaces via the oxidative
self-polymerization of dopamine, collagen is
immobilized onto dural substitutes, possibly
leading to enhancement of the efficiency and
effectiveness of the duraplasty [46, 47].
4.4

Electrospinning technology

This is a special fiber manufacturing technology
that uses an electric field to weave filaments
formed by polymer solutions into dural substitutes. With the development of electrospinning
technology, filaments can be knitted into multilayer scaffolds similar to natural dural fibers
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by controlling the direction of the fibers [46, 48].
By changing the composition of the biomimetic
material polymer, biological activity can be
added to dural substitutes, allowing control of
the degradation, watertightness, and mechanical
strength of the grafts [46, 49, 50].

5

Dura mater and meningeal lymphatic
vessels

Louveau et al. first discovered the presence of
lymphatic vessels in the dura mater in 2015,
overturning the long-standing misconception
that there are no lymphatic vessels in the central
nervous system [2]. Meningeal lymphatic vessels
are an important part of the lymphatic circulation
of the central nervous system. They play a crucial
role in the discharge of metabolic wastes in the
brain, regulation of intracranial tissue fluid volume,
and communication of the peripheral immune
system [51, 52]. Some scholars have reported
that the loss of meningeal lymphatic function
can affect the prognosis of Alzheimer’s disease,
stroke, and other neurological diseases [53–55].
With our deepened understanding of meningeal
lymphatic function, higher requirements for the
recovery of lymphatic structure and function
are needed urgently in duraplasty. The question
of how to promote better reconstruction of
meningeal lymphatic vessels may become a
significant issue in the field of dural substitutes.

6

Conclusions and prospects

Much progress in dural repair has been achieved
over the past hundred years, but dural substitutes
still cannot completely avoid the occurrence of
immune rejection, cerebrospinal fluid leakage, and
other complications. Currently, dural substitutes
lack the properties of perfect biomimetic structure,
ideal tissue compatibility, and degradation in
accordance with the remodeling process. Each
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dural substitute has its own shortcomings, and
there is room for further improvement. It is urgent
that we develop a new generation of dural
substitutes with better clinical effects. Therefore,
the mechanism of dural replacement repair needs
to be further studied and explored, and new
raw materials also need to be explored. With the
rapid development of materials science and an
effective combination of basic research and clinical
study, we believe that the problem of dural defect
repair will be solved successfully.
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